Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04806399 · ClinicalTrials.gov registry record · NA
Improving Utilization of Lung Cancer Screening in Underserved PA Populations
A NA study of Lung Cancer, sponsored by American College of Radiology.
- Active
- Registry status
- NA
- Development phase
- 2,500
- Enrollment target
- 2
- Study locations
NCT04806399: Active NA study of Lung Cancer, sponsored by American College of Radiology.
NCT04806399 is a NA study of Lung Cancer that is active but no longer recruiting, run by American College of Radiology. The registered enrollment target is 2,500 participants, above the 930-participant average among 409 other Lung Cancer trials with a reported enrollment target (169% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04806399, a NA study of Lung Cancer, is active but no longer recruiting, sponsored by American College of Radiology.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 2,500 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is an interventional study intended to assess the impact of a centralized outreach intervention that includes shared decision-making about lung cancer screening (LCS) in LCS-eligible primary care patients. The study's goal is to increase LCS rates compared to usual care and thus reduce lung cancer deaths.
Primary Outcome
Implement a centralized outreach intervention that includes shared decision-making (SDM) about lung cancer screening (LCS) (screening eligibility assessment, education, and decision support) in LCS-eligible primary care patients. The study's ultimate goal is to increase LCS rates compared to usual care and thus reduce lung cancer deaths.
Conditions Studied
Interventions
- OTHER Educational Materials and Decision Counseling
Study Locations (2)
Pennsylvania
- Lehigh Valley Health Network - Allentown
- Jefferson Health System - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2023-03-30 |
| Est. Completion | 2024-11 |
| Phase | NA |
What the registry record for NCT04806399 still lists
NCT04806399 is an interventional study that assigns participants to a tested intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, above the 930-participant average among 409 other Lung Cancer trials with a reported enrollment target (169% higher).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Educational Materials and Decision Counseling is the first listed.
NCT04806399 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04806399 about?
NCT04806399 is a clinical study titled "Improving Utilization of Lung Cancer Screening in Underserved PA Populations". This study is an interventional study intended to assess the impact of a centralized outreach intervention that includes shared decision-making about lung cancer screening (LCS) in LCS-eligible primary care patients. The study's goal is to increase LCS rates compared to usual care and thus reduce lu...
What is the current status of trial NCT04806399?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 2,500 participants. The study started on 2023-03-30. Estimated completion is 2024-11.
What conditions does trial NCT04806399 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT04806399?
The interventions under investigation include: Educational Materials and Decision Counseling (OTHER).
Who is sponsoring clinical trial NCT04806399?
This trial is sponsored by American College of Radiology, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04806399 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04806399's enrollment target sits among peer trials
2,500 22nd of 409 higher than 388 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI